IDX — Integral Diagnostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for Integral Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	R2020 June 30th	2021 June 30th	2022 June 30th	R2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	58	62.2	123	33.9	42.4
Net Total Accounts Receivable
Net Total Receivables	12	18.3	24.3	23.9	27.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	76.5	82.3	154	62.7	74.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	190	211	231	282	270
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	587	655	783	824	744
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	76.2	77.9	80	82.7	85.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	359	400	436	451	443
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	228	255	347	373	302
Total Liabilities & Shareholders' Equity	587	655	783	824	744
Total Common Shares Outstanding